Post Coronary Artery Bypass Graft (CABG) Study

PHASE3CompletedINTERVENTIONAL

Timeline

Start Date

April 30, 1987

Study Completion Date

December 31, 1998

Conditions

Cardiovascular DiseasesCoronary DiseaseHeart DiseasesMyocardial Ischemia

Interventions

DRUG

lovastatin

DRUG

cholestyramine

DRUG

warfarin

All Listed Sponsors

lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT00000463 - Post Coronary Artery Bypass Graft (CABG) Study | Biotech Hunter | Biotech Hunter